Cargando…
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
Successful advances in the treatment of advanced malignant diseases rely on recruitment of patients into clinical trials of novel agents. However, there is a genuine concern for the welfare of individual patients. The aim of this study was to examine motives of patients entering early clinical trial...
Autores principales: | Nurgat, Z A, Craig, W, Campbell, N C, Bissett, J D, Cassidy, J, Nicolson, M C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361930/ https://www.ncbi.nlm.nih.gov/pubmed/15770219 http://dx.doi.org/10.1038/sj.bjc.6602423 |
Ejemplares similares
-
Phase I and pharmacokinetic study of D-verapamil and doxorubicin.
por: Bissett, D., et al.
Publicado: (1991) -
Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma
por: Park, S R, et al.
Publicado: (2006) -
Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial
por: Stathopoulos, G P, et al.
Publicado: (2005) -
Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials
por: Manton, Kerry J, et al.
Publicado: (2019) -
OSAS Surgery and Postoperative Discomfort: Phase I Surgery versus Phase II Surgery
por: Gasparini, Giulio, et al.
Publicado: (2015)